$1.17
2.63%
Nasdaq, Jan 02, 10:00 pm CET
ISIN
US4626841013
Symbol
IRIX

IRIDEX Corporation Stock price

$1.17
+0.25 26.73% 1M
+0.26 28.54% 6M
+0.03 2.63% YTD
-0.66 36.07% 1Y
-0.84 41.79% 3Y
-1.01 46.33% 5Y
-7.63 86.70% 10Y
-6.69 85.11% 20Y
Nasdaq, Closing price Fri, Jan 02 2026
+0.03 2.63%

Key metrics

Basic
Market capitalization
$20.1m
Enterprise Value
$18.2m
Net debt
positive
Cash
$5.6m
Shares outstanding
17.1m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.4 | 0.4
EV/Sales
0.4 | 0.3
EV/FCF
negative
P/B
4.3
Financial Health
Equity Ratio
7.2%
Return on Equity
-424.9%
ROCE
-19.2%
ROIC
-22.1%
Debt/Equity
0.8
Financials (TTM | estimate)
Revenue
$50.7m | $53.3m
EBITDA
$-2.6m | $-2.6m
EBIT
$-3.1m | $-5.0m
Net Income
$-5.1m | $-4.7m
Free Cash Flow
$-4.0m
Growth (TTM | estimate)
Revenue
4.6% | 9.6%
EBITDA
74.0% | 67.0%
EBIT
71.9% | 39.8%
Net Income
53.9% | 47.3%
Free Cash Flow
43.0%
Margin (TTM | estimate)
Gross
38.2%
EBITDA
-5.0% | -4.8%
EBIT
-6.0%
Net
-10.0% | -8.8%
Free Cash Flow
-7.9%
More
EPS
$-0.3
FCF per Share
$-0.2
Short interest
2.0%
Employees
93
Rev per Employee
$520.0k
Show more

Is IRIDEX Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

IRIDEX Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a IRIDEX Corporation forecast:

3x Hold
50%
3x Sell
50%

Analyst Opinions

6 Analysts have issued a IRIDEX Corporation forecast:

Hold
50%
Sell
50%

Financial data from IRIDEX Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
51 51
5% 5%
100%
- Direct Costs 31 31
6% 6%
62%
19 19
3% 3%
38%
- Selling and Administrative Expenses 19 19
22% 22%
37%
- Research and Development Expense 3.83 3.83
36% 36%
8%
-2.55 -2.55
74% 74%
-5%
- Depreciation and Amortization 0.51 0.51
52% 52%
1%
EBIT (Operating Income) EBIT -3.06 -3.06
72% 72%
-6%
Net Profit -5.09 -5.09
54% 54%
-10%

In millions USD.

Don't miss a Thing! We will send you all news about IRIDEX Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

IRIDEX Corporation Stock News

Neutral
GlobeNewsWire
25 days ago
MOUNTAIN VIEW, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced a recently published independent, retrospective study in Ophthalmology and Therapy. The study demonstrates that retreatm...
Neutral
GlobeNewsWire
28 days ago
MOUNTAIN VIEW, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced a newly published study in Translational Vision Science & Technology (TVST) examining the thermal dynamics of transscler...
Neutral
GlobeNewsWire
about one month ago
MOUNTAIN VIEW, Calif., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced plans to participate in the upcoming Sidoti Year-End Virtual Investor Conference.
More IRIDEX Corporation News

Company Profile

IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices and consumable instrumentation for the ophthalmology market. Its products include lasers, laser delivery and glaucoma devices, retinal surgical instruments, veterinary, and ENT. The company was founded by Eduardo Arias, Theodore A. Boutacoff, David M. Buzawa and James L. Donovan in February 1989 and is headquartered in Mountain View, CA.

Head office United States
CEO Patrick Mercer
Employees 93
Founded 1989
Website www.iridex.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today